Conditions: Type 2 Diabetes Mellitus
Keywords: diabetes; exenatide once weekly; Byetta; glargine; Lantus; Amylin; Lilly
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 427
Healthy volunteers: no

Brief summary:
The objectives of this clinical trial are to compare the effects of exenatide once weekly and insulin glargine on blood glucose control, body weight, lipids, safety, and tolerability.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: exenatide once weekly intervention 2: insulin glargine
Intervention descriptions: intervention 1: subcutaneous injection, 2.0mg, once a week; intervention 2: subcutaneous injection, titrated to achieve fasting serum glucose target, once a day

Protocol document: